The global alopecia market is projected to be worth USD 5,250.8 Million by 2027, according to a current analysis by Emergen Research. The alopecia market is projected to experience rapid growth by the year 2027. The rising occurrence of alopecia is a significant factor driving the growth of the market. For instance, alopecia areata, a chronic, autoimmune disorder that affects growing hair follicles resulting in nonscarring focal hair loss, has global prevalence.

Key participants include Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc., Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Concert Pharmaceuticals Inc., GlaxoSmithKline PLC, Aclaris Therapeutics Inc., and HCell Inc., among others.

To get leading market solutions, visit the link below:

https://www.emergenresearch.co....m/industry-report/al